New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
10x Genomics, Inc.
TXG
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Medical - Healthcare Information Services

Next Earning date - 20 Feb 2025

1B

Medical - Healthcare Information Services

Next Earning date - 20 Feb 2025

12.00USD

Shape0.18 ( 1.52%)
Market Closed (as of Feb 13, 00:59 EDT)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

106%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

77%

Quote Panel

Shape
Updated February 13, 2025
1W -15.79 % 1M -22.28 % 3M -15.01 % 1Y -75.04 %

Key Metrics

Shape
  • Market Cap

    1.45B


  • Shares Outstanding

    121.05M


  • Share in Float

    113.37M


  • Dividende

    0


  • Earning Date

    20 Feb 2025


  • Price Target

    12


  • Average Volume

    2.05M


  • Beta

    1.873


  • Range

    11.5501-51.22


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.10xgenomics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

TXG

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$631M

Shape316%

2025-Revenue

$1.31

Shape-337%

2025-EPS

$216M

Shape-814%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Hold

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Hold

2024-07-22

Now: Buy

Deutsche Bank

downgrade

Previous: Buy

2024-07-10

Now: Hold

Wolfe Research

downgrade

Previous: Not converted

2024-06-27

Now: Peer Perform

Guggenheim

downgrade

Previous: Not converted

2024-06-25

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.15
vs -0.16

Q1.23

arrow
arrow

N/A

-0.44
vs -0.38

Q2.23

arrow
arrow

N/A

-0.53
vs -0.57

Q3.23

arrow
arrow

N/A

-0.51
vs -0.37

Q4.23

arrow
arrow

N/A

-0.41
vs -0.15

Q1.24

arrow
arrow

N/A

-0.50
vs -0.44

Q2.24

arrow
arrow

N/A

-0.32
vs -0.53

Q3.24

arrow
arrow

N/A

-0.30
vs -0.51

Q4.24

arrow
arrow

N/A

-0.30
vs -0.41

Q1.25

arrow
arrow

N/A

-0.41
vs -0.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+9%

156.2M  vs 143.5M

Q1.23

arrow
arrow

+17%

134.3M  vs 114.5M

Q2.23

arrow
arrow

+28%

146.8M  vs 114.6M

Q3.23

arrow
arrow

+17%

153.6M  vs 131.1M

Q4.23

arrow
arrow

+18%

184M  vs 156.2M

Q1.24

arrow
arrow

+5%

141M  vs 134.3M

Q2.24

arrow
arrow

+4%

153.1M  vs 146.8M

Q3.24

arrow
arrow

-1%

151.7M  vs 153.6M

Q4.24

arrow
arrow

-13%

159.8M  vs 184M

Q1.25

arrow
arrow

+1%

141.9M  vs 141M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-2%

-0.02
vs -0.05

Q1.23

arrow
arrow

-6%

-0.06
vs -0.02

Q2.23

arrow
arrow

-8%

-0.08
vs -0.06

Q3.23

arrow
arrow

-12%

-0.12
vs -0.08

Q4.23

arrow
arrow

-7%

-0.07
vs -0.12

Q1.24

arrow
arrow

-8%

-0.08
vs -0.07

Q2.24

arrow
arrow

-5%

-0.05
vs -0.08

Q3.24

arrow
arrow

-5%

-0.05
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

266

266
vs 219

21%

Q1.23

arrow
arrow

257

257
vs 266

-3%

Q2.23

arrow
arrow

278

278
vs 257

8%

Q3.23

arrow
arrow

264

264
vs 278

-5%

Q4.23

arrow
arrow

279

279
vs 264

6%

Q1.24

arrow
arrow

293

293
vs 279

5%

Q2.24

arrow
arrow

264

264
vs 293

-10%

Q3.24

arrow
arrow

269

269
vs 264

2%

Earnings Growth

Latest News